- Home
- EXAI vs ATLC Comparison
EXAI vs ATLC Comparison
Compare EXAI & ATLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAI
- ATLC
- Stock Information
- Founded
- EXAI 2012
- ATLC 1996
- Country
- EXAI United Kingdom
- ATLC United States
- Employees
- EXAI N/A
- ATLC N/A
- Industry
- EXAI Biotechnology: Biological Products (No Diagnostic Substances)
- ATLC Finance: Consumer Services
- Sector
- EXAI Health Care
- ATLC Finance
- Exchange
- EXAI Nasdaq
- ATLC Nasdaq
- Market Cap
- EXAI 635.8M
- ATLC 544.2M
- IPO Year
- EXAI 2021
- ATLC 1999
- Fundamental
- Price
- EXAI $5.28
- ATLC $42.21
- Analyst Decision
- EXAI Hold
- ATLC Buy
- Analyst Count
- EXAI 4
- ATLC 3
- Target Price
- EXAI $7.00
- ATLC $41.00
- AVG Volume (30 Days)
- EXAI 485.2K
- ATLC 16.1K
- Earning Date
- EXAI 11-15-2024
- ATLC 11-15-2024
- Dividend Yield
- EXAI N/A
- ATLC N/A
- EPS Growth
- EXAI N/A
- ATLC N/A
- EPS
- EXAI N/A
- ATLC 4.21
- Revenue
- EXAI $26,566,153.00
- ATLC $362,247,000.00
- Revenue This Year
- EXAI $156.33
- ATLC N/A
- Revenue Next Year
- EXAI N/A
- ATLC $12.76
- P/E Ratio
- EXAI N/A
- ATLC $9.97
- Revenue Growth
- EXAI N/A
- ATLC 3.83
- 52 Week Low
- EXAI $3.80
- ATLC $23.10
- 52 Week High
- EXAI $7.91
- ATLC $42.55
- Technical
- Relative Strength Index (RSI)
- EXAI 57.06
- ATLC 80.95
- Support Level
- EXAI $4.80
- ATLC $36.86
- Resistance Level
- EXAI $5.26
- ATLC $38.54
- Average True Range (ATR)
- EXAI 0.23
- ATLC 1.14
- MACD
- EXAI 0.03
- ATLC 0.40
- Stochastic Oscillator
- EXAI 81.16
- ATLC 95.27
About EXAI Exscientia Plc
Exscientia PLC is engaged in the application of artificial intelligence (AI) and machine learning (ML) to the discovery and design of novel therapeutic compounds. The company's technology platform combines human and computational capabilities to accelerate the process of designing novel, safe, and efficacious compounds for clinical testing in humans. The company is focused on the discovery and development of small-molecule drug candidates.
About ATLC Atlanticus Holdings Corporation
Atlanticus Holdings Corp invests in the financial services industry. It provides various credit and related financial services and products to or associated with the financially underserved consumer credit market. The operating business segments are the Credit as a Service and the Auto Finance segment. It generates maximum revenue from the Credit as a Service segment.